This work is licensed under the Creative Commons Attribution 4.0 International License.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–249. doi: 10.3322/caac.21660SungHFerlayJSiegelRLLaversanneMSoerjomataramIJemalAGlobal Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries20217120924910.3322/caac.21660Open DOISearch in Google Scholar
Institute of Oncology Ljubljana. Cancer registry. [Internet]. [cited 2023 Jan 22]. Available at: http://www.slora.si/en/stevilo-zivih-bolnikovInstitute of Oncology Ljubljana[cited 2023 Jan 22]. Available at: http://www.slora.si/en/stevilo-zivih-bolnikovSearch in Google Scholar
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–76. doi: 10.1093/jnci/85.5.365AaronsonNKAhmedzaiSBergmanBBullingerMCullADuezNJThe European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology1993853657610.1093/jnci/85.5.365Open DOISearch in Google Scholar
Michels FAS, Latorre MDRDDO, Maciel MDS. Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer. Rev Bras Epidemiol 2013; 16: 352–363. doi: 10.1590/S1415-790X2013000200011MichelsFASLatorreMDRDDOMacielMDSValidity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer20131635236310.1590/S1415-790X2013000200011Open DOISearch in Google Scholar
Giesinger JM, Kieffer JM, Fayers PM, Groenvold M, Petersen MA, Scott NW. EORTC Quality of Life Group Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol 2016; 69: 79–88. doi: 10.1016/j.jclinepi.2015.08.007GiesingerJMKiefferJMFayersPMGroenvoldMPetersenMAScottNWEORTC Quality of Life Group Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust201669798810.1016/j.jclinepi.2015.08.007Open DOISearch in Google Scholar
Schmidt ME, Scherer S, Wiskemann J, Steindorf K. Return to work after breast cancer: the role of treatment-related side effects and potential impact on quality of life. Eur J Cancer Care 2019; 28: e13051. doi: 10.1111/ecc.13051SchmidtMESchererSWiskemannJSteindorfKReturn to work after breast cancer: the role of treatment-related side effects and potential impact on quality of life201928e1305110.1111/ecc.13051Open DOISearch in Google Scholar
von Ah D, Crouch A. Relationship of perceived everyday cognitive function and work engagement in breast cancer survivors. Support Care Cancer 2021; 29: 303–4309. doi: 10.1007/s00520-020-05950-8von AhDCrouchARelationship of perceived everyday cognitive function and work engagement in breast cancer survivors202129303430910.1007/s00520-020-05950-8Open DOISearch in Google Scholar
Arndt V, Merx H, Stürmer T, Stegmaier C, Ziegler H, Brenner H. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer 2004; 40: 673–80. doi: 10.1016/j.ejca.2003.12.007ArndtVMerxHStürmerTStegmaierCZieglerHBrennerHAge-specific detriments to quality of life among breast cancer patients one year after diagnosis2004406738010.1016/j.ejca.2003.12.007Open DOISearch in Google Scholar
Ahn SH, Park BW, Noh DY, Nam SJ, Lee ES, Lee MK, et al. Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol 2007; 18: 173–82. doi: 10.1093/annonc/mdl333. Erratum in: Ann Oncol 2009; 20: 1753–4.AhnSHParkBWNohDYNamSJLeeESLeeMKHealth-related quality of life in disease-free survivors of breast cancer with the general population2007181738210.1093/annonc/mdl333Erratum in: Ann Oncol 2009; 20: 1753–4.Open DOISearch in Google Scholar
Grašič Kuhar C, Gortnar Cepeda T, Kovač T, Kukar M, Ružić Gorenjec N. Mobile app for symptom management and associated quality of life during systemic treatment in early stage breast cancer: nonrandomized controlled prospective cohort study. JMIR Mhealth Uhealth 2020; 8: e17408. doi: 10.2196/17408Grašič KuharCGortnar CepedaTKovačTKukarMRužić GorenjecNMobile app for symptom management and associated quality of life during systemic treatment in early stage breast cancer: nonrandomized controlled prospective cohort study20208e1740810.2196/17408Open DOISearch in Google Scholar
Velenik V, Secerov-Ermenc A, But-Hadzic J, Zadnik V. Health-related quality of life assessed by the EORTC QLQ-C30 Questionnaire in the general Slovenian population. Radiol Oncol 2017; 51: 342–50. doi: 10.1515/raon-2017-0021VelenikVSecerov-ErmencABut-HadzicJZadnikVHealth-related quality of life assessed by the EORTC QLQ-C30 Questionnaire in the general Slovenian population2017513425010.1515/raon-2017-0021Open DOISearch in Google Scholar
Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, et al; ESMO Guidelines Working Group. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl 6): vi7–23. doi: 10.1093/annonc/mdt284SenkusEKyriakidesSPenault-LlorcaFPoortmansPThompsonAZackrissonSESMO Guidelines Working GroupPrimary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up201324Suppl 6vi72310.1093/annonc/mdt284Open DOISearch in Google Scholar
Fayers P, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 scoring manual. 3rd edition. Brussels: EORTC Brussels; 2001. [Internet]. [cited 2020 Jun 22]. Available at: https://www.eortc.org/app/uploads/sites/2/2018/02/SCmanual.pdfFayersPBjordalKGroenvoldMCurranDBottomleyA3rd editionBrusselsEORTC Brussels2001[Internet]. [cited 2020 Jun 22]. Available at: https://www.eortc.org/app/uploads/sites/2/2018/02/SCmanual.pdfSearch in Google Scholar
Scoring of the QLQ-C30 Summary Score. [Internet]. [cited 2022 Nov 26]. Available at: https://qol.eortc.org/app/uploads/sites/2/2018/02/scoring_of_the_qlq-c30_summary_score.pdf[cited 2022 Nov 26]. Available at: https://qol.eortc.org/app/uploads/sites/2/2018/02/scoring_of_the_qlq-c30_summary_score.pdfSearch in Google Scholar
Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139–44. doi: 10.1200/JCO.1998.16.1.139OsobaDRodriguesGMylesJZeeBPaterJInterpreting the significance of changes in health-related quality-of-life scores1998161394410.1200/JCO.1998.16.1.139Open DOISearch in Google Scholar
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2020. [Internet]. [cited 2021 Jun 6]. Available at: https://www.R-project.org/R Core TeamR Foundation for Statistical ComputingVienna, Austria2020[Internet]. [cited 2021 Jun 6]. Available at: https://www.R-project.org/Search in Google Scholar
Doege D, Thong MS, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, et al. Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany. Breast Cancer Res Treat 2019; 175: 499–510. doi: 10.1007/s10549-019-05188-xDoegeDThongMSKoch-GallenkampLBertramHEberleAHolleczekBHealth-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany201917549951010.1007/s10549-019-05188-xOpen DOISearch in Google Scholar
Ferreira AR, Di Meglio A, Pistilli B, Gbenou AS, El-Mouhebb M, Dauchy S, et al. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol 2019; 30: 1784–95. doi: 10.1093/annonc/mdz298FerreiraARDi MeglioAPistilliBGbenouASEl-MouhebbMDauchySDifferential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis20193017849510.1093/annonc/mdz298Open DOISearch in Google Scholar
Husson O, de Rooij BH, Kieffer J, Oerlemans S, Mols F, Aaronson NK, et al. The EORTC QLQ-C30 Summary Score as prognostic factor for survival of patients with cancer in the “real-world”: Results from the Population-Based PROFILES Registry. Oncologist 2020; 25: e722–e32. doi: 10.1634/theoncologist.2019-0348HussonOde RooijBHKiefferJOerlemansSMolsFAaronsonNKThe EORTC QLQ-C30 Summary Score as prognostic factor for survival of patients with cancer in the “real-world”: Results from the Population-Based PROFILES Registry202025e722e3210.1634/theoncologist.2019-0348Open DOISearch in Google Scholar
Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 2005; 23: 4945–53. doi: 10.1200/JCO.2005.03.475.ArndtVMerxHStegmaierCZieglerHBrennerHPersistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer20052349455310.1200/JCO.2005.03.475.Open DOISearch in Google Scholar
Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M. It's not over when it's over: long-term symptoms in cancer survivors – a systematic review. Int J Psychiatry Med 2010; 40: 163–181. doi:10.2190/PM.40.2.cHarringtonCBHansenJAMoskowitzMToddBLFeuersteinMIt's not over when it's over: long-term symptoms in cancer survivors – a systematic review201040163181doi:10.2190/PM.40.2.cSearch in Google Scholar
de Ligt KM, Heins M, Verloop J, Ezendam NPM, Smorenburg CH, Korevaar JC, et al. The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors. Breast Cancer Res Treat 2019; 178: 703–11. doi: 10.1007/s10549-019-05433-3de LigtKMHeinsMVerloopJEzendamNPMSmorenburgCHKorevaarJCThe impact of health symptoms on health-related quality of life in early-stage breast cancer survivors20191787031110.1007/s10549-019-05433-3Open DOISearch in Google Scholar
van der Willik KD, Koppelmans V, Hauptmann M, Compter A, Ikram MA, Schagen SB. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study. Breast Cancer Res 2018; 20: 135. doi: 10.1186/s13058-018-1062-3van der WillikKDKoppelmansVHauptmannMCompterAIkramMASchagenSBInflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study20182013510.1186/s13058-018-1062-3Open DOISearch in Google Scholar
Zehra S, Doyle F, Barry M, Walsh S, Kell MR. Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis. Breast Cancer 2020; 27: 534–66. doi: 10.1007/s12282-020-01076-1ZehraSDoyleFBarryMWalshSKellMRHealth-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis2020275346610.1007/s12282-020-01076-1Open DOISearch in Google Scholar
Yfantis A, Sarafis P, Moisoglou I, Tolia M, Intas G, Tiniakou I, et al. How breast cancer treatments affect the quality of life of women with non-metastatic breast cancer one year after surgical treatment: a cross-sectional study in Greece. BMC Surg 2020; 20: 210. doi: 10.1186/s12893-020-00871-zYfantisASarafisPMoisoglouIToliaMIntasGTiniakouIHow breast cancer treatments affect the quality of life of women with non-metastatic breast cancer one year after surgical treatment: a cross-sectional study in Greece20202021010.1186/s12893-020-00871-zOpen DOISearch in Google Scholar
Yoon J, Malin JL, Tao ML, Tisnado DM, Adams JL, Timmer MJ, et al. Symptoms after breast cancer treatment: are they influenced by patient characteristics? Breast Cancer Res Treat 2008; 108: 153–165. doi: 10.1007/s10549-007-9599-3YoonJMalinJLTaoMLTisnadoDMAdamsJLTimmerMJSymptoms after breast cancer treatment: are they influenced by patient characteristics?200810815316510.1007/s10549-007-9599-3Open DOISearch in Google Scholar
Joly F, Lange M, Dos Santos M, Vaz-Luis I, Di Meglio A. Long-term fatigue and cognitive disorders in breast cancer survivors. Cancers 2019; 11: 1896. doi: 10.3390/cancers11121896JolyFLangeMDos SantosMVaz-LuisIDi MeglioALong-term fatigue and cognitive disorders in breast cancer survivors201911189610.3390/cancers11121896Open DOISearch in Google Scholar
Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol 2019; 30: 1925–40. doi: 10.1093/annonc/mdz410LangeMJolyFVardyJAhlesTDuboisMTronLCancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors20193019254010.1093/annonc/mdz410Open DOISearch in Google Scholar
National Comprehensive Cancer Networ. NCCN guidelines for supportive care. [Internet]. [cited 2021 Jun 6]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdfNational Comprehensive Cancer Networ[cited 2021 Jun 6]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdfSearch in Google Scholar
Puetz TW, Herring MP. Differential effects of exercise on cancer-related fatigue during and following treatment: a meta-analysis. Am J Prev Med 2012; 43: e1–24. doi: 10.1016/j.amepre.2012.04.027PuetzTWHerringMPDifferential effects of exercise on cancer-related fatigue during and following treatment: a meta-analysis201243e12410.1016/j.amepre.2012.04.027Open DOISearch in Google Scholar